The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Mode has received irrevocable commitments from new and existing investors to subscribe for £1,935,000 of convertible loan notes. The loan notes, which carry a coupon of 8%, are convertible into Mode's Ordinary Shares.
Mode CEO comments: "2021 was a big year for Mode. Our aim was to grow our user base and give them the products they want. Put simply, we achieved what we set out to do.
Mode is a rarity on the LSE - a crypto-driven fintech which has obtained regulatory oversight via EMI and FCA registration. Those accreditations demonstrate that we are leading the way in the UK's digital asset industry. The prudent and sustainable approach we have adopted from day one will also help the firm navigate current market volatility, thanks to our strong risk management framework. Clearly 2021 has been a year of innovation, development and growth and we will continue to build on this momentum in 2022."
what there not to like about mode...
15% up
nice
20% free float
mode as deep pockets ....
Some will be 80% plus down currently here., so a big rise needed for many holders
have to ave down x2
from 40p to 15p
i think figures will be aroung 5 mil
andup turn in the app
low freefloat with mode
9.9 to buy now
heading up
https://audioboom.com/posts/8026408-the-sunday-roast-with-jonathan-rowland-executive-chairman-of-mode-global-holdings-lse-mode
time will tell
top up
Rita Liu, Mode CEO comments: "2022 is a big year for Mode and these two new additions signal our intentions. Mike and David are two industry heavyweights that will help not only in terms of strategy but will also help us grow our networks and drive growth. I'd like to formally welcome both to Mode and look forward to what we can achieve together"
boom
market must see this as good thing
1.75/1.80
n t to buy
well said
hoiding at 3p
waiting for it to pop again
3.50 to buy
moving back up
Formal Sale Process Update
On 2 November 2021, the Company announced the launch of a strategic review and commencement of a Formal Sale Process in which it was also noted that, at that time, neither the Company nor Lord Drayson were in discussions with any potential offeror or in receipt of a possible offer for the Company. Since then, JP Morgan and Peel Hunt (joint financial advisers to the Company) have contacted a broad range of corporates and financial sponsors to solicit interest in an offer for the Company or strategic investment into the Company. On 14 January 2022, the Company announced that a number of parties were having more detailed discussions with the Company under the terms of non-disclosure agreements. Discussions remain ongoing with a small number of parties who may or may not make an offer for the Company or some other strategic investment in or transaction with the Company.
Sensyne Health PLC, down 71% at 2.90p, 12-month range 1.00p-178.00p. The clinical artificial intelligence company warns that without further financing it will not be able to continue beyond this month. Sensyne explains it has entered a non-binding term sheet with noteholders to amend the original note purchase agreement to provide an additional GBP15 million in financing. "Shareholders' attention is specifically drawn to the proposed term to cancel the company's shares from trading on AIM and the highly dilutive impact of granting conversion rights to the noteholders and the proposed change in exercise price of the warrants associated with the loan notes," it says. Chief Executive & Founder Paul Drayson steps down from the board with immediate effect. He will be replaced by Alex Snow, former CEO of Landsdowne Partners UK LLP, who has "extensive experience" in finance and the commercialisation of science.
1.39